Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials
By J. Geleijnse, E. Giltay, Diederick E. Grobbee, A. Donders, F. Kok. Journal of Hypertension, 2002
723 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/1a819125e0e4f0be5cc6553c06c45cf61b5fc6e4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- B. Ribeiro
- Jason H. Y. Wu
- P. G. Pinho
- E. Rimm
- P. Andrade
- A. Lichtenstein
- M. Chung
- P. Baptista
Citations in the corpus
- Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. (2006, methodology): “[5] Geleijnse JM, Giltay EJ, Grobbee DE, Donders ART, Kok FJ.”
- Fish intake, contaminants, and human health: evaluating the risks and the benefits. (2006, background): “n-3 PUFAs influence several cardiovascular risk factors.(18,19,43,49,50,60-75,79-84) Effects occur within weeks of intake and may result from altered membrane fluidity and receptor responses following incorporation of n-3 PUFAs into cell membranes(76,77) and direct binding of n-3 PUFAs to intracellu”
- Fatty acid composition of wild edible mushrooms species: A comparative study (2009, background): “Beyond these, many works showed that they can also decrease the total amount of fat in blood (cholesterol), reducing the risk of cardiovascular diseases [7,30–32].”
- 2007 ESH‐ESC Guidelines for the management of arterial hypertension (2007, background): “(500,540,541) In hypertensive individuals, average systolic and diastolic blood pressure reductions were 4.”
- Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. (2011, background): “n-3 PUFA consumption reduces resting heart rate (HR) and systolic and diastolic blood pressure (53,54).”